Advice
following an abbreviated submission
ethinylestradiol 30microgram/levonorgestrel 150microgram (Rigevidon®): is accepted for use within NHS Scotland.
Indication under review: oral contraception.
For patients in whom ethinylestradiol/levonorgestrel is an appropriate contraceptive, Rigevidon® provides an alternative to existing preparations at a lower cost.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- ethinylestradiol 30mcg and levonorgestrel 150mcg (Rigevidon)
- SMC ID:
- 646/10
- Indication:
- Oral contraception
- Pharmaceutical company
- Consilient Health Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 October 2010